Lower versus Standard INR Targets in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Arjun Pandey(University of Toronto), Richard Whitlock(McMaster University), Emilie P. Belley‐Côté(McMaster University), William F. McIntyre(Population Health Research Institute), Ke Xu(Shanghai Jiao Tong University), Renato D. Lópes(Duke University), Mark Crowther(McMaster University), John W. Eikelboom(King's College Hospital), Saurabh Gupta(McMaster University Medical Centre), Li Zhang(McMaster University), Olivia Cook(McMaster University)
Cited by 32
Related Papers
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
|Intensive Care Medicine|2021|5k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021
|Critical Care Medicine|2021|2.7k
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
|New England Journal of Medicine|2017|2.4k